Drugs to treat Obesity: Are they all harmful?
Main Article Content
Abstract
Obesity is a serious health problem in our society. The management of this disorder is considered by many as one of the most difficult and frustrating in the practice of clinical medicine. Because of the undesirable effects of a group of drugs and the huge publicity that they created, a good resource for the treatments of obesity is being displaced. This is a small review of this topic, hoping, to serve as a little contribution for those who struggle day-by-day helping people with the heavy burden of losing weight.
Downloads
Article Details
Los autores que publiquen en la Revista ACTA ACADÉMICA aceptan las siguientes condiciones:
De acuerdo con la legislación de derechos de autor, la Revista ACTA ACADÉMICA reconoce y respeta el derecho moral de los autores, así como la titularidad del derecho patrimonial, el cual será cedido a la revista para su difusión en acceso abierto.
La Revista ACTA ACADÉMICA no realiza cargos a las/los autoras/es por enviar y procesar artículos para su publicación.
Todos los textos publicados por la Revista ACTA ACADÉMICA –sin excepción– se distribuyen amparados bajo la licencia Creative Commons que permite a terceros utilizar lo publicado siempre que mencionen la autoría del trabajo y a la primera publicación en esta revista.
References
2. Atkinson RL, "Use of drugs in the treatment of obesity". Annu Rev. Nutr. 1997. 17:383-403.
3. Berger M. 1992 "Pharmacological treatment of obesity: digestion and absortion inhibitors -clinical perspective". Am J. Clin. Nut. 55 318-195.
4. Bray GA, "Barriers to the treatment of obesity". Ann Intern Med. 1991; 115:152-153.
5. Bray GA, "Use and abuse of appetite-suppressant drugs in the treatment of obesity". Ann Intern Med. 1993; 119 (7 pt 2):707-713.
6. Connolly H, Crary J, McGoon M, Hensrud D, Edwards W, Schaff H, "Valvula heart disease associated with fenfluramine-phentermine". N. Engl J. Med 1997; 337:581-589.
7. Doctor's Guide to Medical & Other News. FDA Panel's Vote Over Weight-Loss Drug Xenical Results in Tie. World Wide Web (service provider), http://www.pslgroup.com/dg/ 61ece.htm.
8. Doctor's Guide to Medical & Other News First Federal Guidelines on Clinical Obesity Released. World Wide Web (service provider). http://www.pslgroup.com/dg/87126.htm.
9. Doctor's Guide to Medical & Other News. MERIDIA Receives FDA Approval Letter for Treatment of Obesity. World Wide Web (service provider), http://www.pslgroup. com/dg/daba.htm.
10. Expert Panel. "Executive summary of the clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults". Arch Intern Med/Vol 158, Sep 28, 1998.
11. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, ChaitBT, fW. 1995. "Weight-reducing effects of the plasma protein encoded by the obese gene". Science 269:543-46.
12. Manson JE, Faich GA, Pharmacotherapy for obesity - do the benefits outweight the risks?" N Engl J Med 1996; 335:659-60.
13. Manson JE, Willett WC, Stampfer MJ, et. al. "Body weight and mortality among women". N Engl J Med 1995; 333: 677-85.
14. McGinnis JM, Forge WH, "Actual causes of death in the United States". JAMA 1993; 270: 2207-12.
15. Pi-Sunger FX. "Medical hazards of obesity". Ann Wern Med. 1993; 199(7 pt 2):655-660.
16. Silverstone T, 1992. "Appetite suppressants: a review". Drugs 43(6):820-36.
17. The miracle that was not fen/phen and Redux. World Wide Web (service provider) http:// www.lexis-nexis.com/universe/do...&_ md5=9bb83a7be9e72e2a3246bf75bc9b52d0.
18. Weintraub M, et. al. 1992. "Long-term weight control: the National Heart, Lung, and Blood Institute funded multimodal intervention study". Clin. Pharmacol. Ther. 51: 581-646.
19. Zollo, A. Jr., Medical Secrets. Philadelphia; Hanley & Belfus 1991; page 489.